The Payer Exchange Podcast Episode 4: NETHERLANDS - Hans Severens on Value-Based Pricing, Disease Severity, and Sustainability Pressures
Listen and subscribe
In this episode, Omar Ali speaks with Hans Severens, a respected academic and former Vice Chair of the Dutch Health Council, who brings deep insight into the work of ZIN and the Netherlands’ evolving HTA framework.
Hans shares how the Dutch approach to value-based pricing is becoming increasingly sophisticated—and why severity of disease may carry more weight than rarity in reimbursement decisions. The conversation also explores the feasibility of sustaining the healthcare system amid rising costs, and the importance of honest trade-offs in payer decision-making.
This episode offers a sharp, system-level view of Dutch payer logic, and raises essential questions for manufacturers working with high-cost therapies and real-world evidence.
“We need to be honest—this isn’t just about rarity. It’s about how severe the condition is, and what we can sustain”
About The Payer Exchange
The Payer Exchange is a podcast from Verpora that explores how payers around the world are navigating complex pricing and access decisions. Hosted by Omar Ali, Verpora’s Head of Payers, each episode features a one-to-one conversation with a payer from a different healthcare system—offering direct insight into the practical realities of drug funding, reimbursement, and health system sustainability.
Listen and subscribe
Next Episode
E5 SPAIN with Jaime Espín →
Disclaimer: This presentation is for educational and informational purposes only, and is not intended as legal or policy advice. This presentation is based on non-confidential intelligence. Views expressed by the speakers are personal opinions and should not be attributed to anyone else. No part of this presentation may be reproduced for commercial purposes without the express permission of Verpora.
